Reduction of ischemic reperfusion edema with corticotropin-releasing factor (CRF) in rat hind limb replantation

Annals of Plastic Surgery

Volumn 38, Issue 4, 1997, Pages 416-420

  Whitney, Timothy M ^a   Wang, Kai Kai ^a   Sternbach, Yaron ^a   Chaklis Haley, Dimitria ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR[9-41]; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CAPILLARY PERMEABILITY; CONFERENCE PAPER; CONTROLLED STUDY; HINDLIMB; INTRAVENOUS DRUG ADMINISTRATION; LEG EDEMA; LIMB AMPUTATION; LIMB ISCHEMIA; LIMB REPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT GAIN;

ANIMALS; CAPILLARY PERMEABILITY; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; HINDLIMB; HORMONE ANTAGONISTS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; ISCHEMIA; PEPTIDE FRAGMENTS; RATS; REPERFUSION INJURY; REPLANTATION;

EID: 0030897562     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-199704000-00018     Document Type: Conference Paper

References (36)

1. Vedder NB, Winn RK, Rice CL, et al. Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear. Proc Natl Acad Sci USA 1990;87:2643-2646
2. Kerrigan CL, Stotland MA. Ischemic reperfusion injury: a review. Microsurgery 1993;14:165-175
3. Pober JS. Cytokine-mediated activation of vascular endothelium, physiology and pathology. Am J Pathol 1988;133(3):426-433
4. Vane JR, Anggard BE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36
5. Davies MG, Hagan P-O. The vascular endothelium: a new horizon. Ann Surg 1993;218:593-609
6. Wedmore CV, Williams TJ. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 1981;289:646-650
7. Lehr HA, Guhlmann A, Nolte D, et al. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest 1991;87:2036-2041
8. Zurier RB. Prostaglandins, leukotrienes and related compounds. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. 4th ed. Philadelphia: WB Saunders, 1993;201-212
9. Stewart AG, Phan LH, Georgiade G. Physiological and pathophysiological roles of nitric oxide. Microsurgery 1994;15:693-702
10. Burnstock G, Relevic V. New insights into the local regulation of blood low by perivascular nerves and endothelium. Br J Plast Surg 1994;47:527-543
11. Wei ET, Serda S, Tian JQ. Protective actions of CRF in thermal injury to rat pawskin. J Pharmacol Exp Ther 1088;247:1082-1085
12. Wei ET, Gao GC. Corticotropin-releasing factor: an inhib- itor of vascular leakage in rat skeletal muscle and brain cortex after injury. Regul Pept 1991;32:93-104
13. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991;43:425-473
14. Ur E, Grossman A. Corticotropin-releasing hormone in health and disease: an update. Acta Endocrinol (Copenh) 1992;127(3):193-199
15. Ritchie JC, Owens MJ, O'Connor LW, et al. Measurement of ACTH and CRF immunoreactivity in adrenal gland and lymphocytes. Soc Neurosci 1986;12:1041 (abstract)
16. Wet ET, Kiang JG. Peptides of the corticoliberin superfamily attenuate thermal and neurogenic inflammation in rat pawskin. Eur J Pharmacol 1989;168:81-86
17. Serda SM, Wei ET. Corticotropin-releasing factor inhibits the acute inflammatory response of rat pawskin to cold injury. Cryobiology 1991;28:185-190
18. Wei ET, Wang JC, Klang JG. Decreased inflammatory responsiveness of hypophysectomized rats to heat is reversed by a corticotropin-releasing factor (CRF) antagonist. Regul Pept 1990;27:317-323
19. Speiss J, Rivier J, Vale W. Sequence analysis of rat hypothalamic corticotropin-releasing factor with the o-phthaldehyde strategy. Biochemistry 1983;22:4341-4346
20. Dashwood MR, Andrews HE, Wei ET. Binding of [125-I] Tyr-corticotropin-releasing factor to rabbit aorta is reduced by removal of the endothelium. Eur J Pharmacol 1987;135:111-112
21. Whitney TM, Bentz M, Johnson PC. Reduction of reperfusion edema with corticotropin-releasing factor. Presented at the Ivy Society. Hershey, PA. March 12, 1993
22. Whitney TM, Bentz M, Johnson PC. Reduction of reperfusion injury edema with corticotropin-releasing factor (CRF): a pilot study. Microsurgery 1996 (submitted for publication)
23. Gao GC, Dashwood MR, Wei ET. Corticotropin-raleasing factor inhibition of substance P-induced vascular leakage in rats: possible sites of action. Peptides 1991;12:639-644
24. Zamboni WA, Roth AC, Russell RC, et al. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reeonstr Surg 1993;91:1110-1123
25. Walter HJ. Corticotropin-releasing factor is contained within perikarya and nerve fibres of rat duodenum. Biochem Biophys Res Commun 1984;122:381-387
26. Kruseman ACN, Linton EA, Lowry PJ, et al. Corticotropin-releasing factor immunoreactivity in human gastrointestinal tract. Lancet 1982;2:1245 [abstract]
27. Kruseman ACN, Linton EA, Ackland J, et al. Heterogenous immunocytochemical reactivities of oCRF-41-like material in the human hypothalamus, pituitary and gastrointestinal tract. Neuroendocrinology 1984;38:212-216
28. Suda T, Tomori N, Tozawa F, et al. Immunoreactive corticotropin and corticotropin-releasing factor in human hypothalamus, adrenal, lung cancer and pheochromocytoma. J Clin Endocrinol Metab 1984;58:919-924
29. Dave JR, Eiden LE, Eskay RL. Corticotropin-releasing factor binding to peripheral tissue and activation of the adenyl cyclase-adenosine 3′,5′-monophosphate system, Endocrinology 1985;116:2152-2159
30. Seibert AF, Thompson WJ, Taylor A, et al. Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP. J Appl Physiol 1992;72:389-395
31. Thomas HA, Ling N, Wei ET. CRF and related peptides as anti-inflammatory agonists. Ann N Y Acad Sci 1993;697:219-228
32. Lampugnani MG, Caveda L, Breviario F, et al. Endothelial cell-to-cell junctions. Structural characteristics and functional role in the regulation of vascular permeability and leukocyte extravasation. Baillieres Clin Haematol 1993;6:539-558
33. Rivier C, Blockade of NO formation augments ACTH release by blood borne interleukin 1-beta: role of vasopressin, prostaglandins and alpha-1 adrenergic receptors. Endocrinology 1995;36:3597-3603
34. Turnbull AV, Rivier C. CRF, vasopressin and prostaglandins mediate, and NO restrains, the HPA response to acute local inflammation in the rat. Endocrinology 1998;137:455-463
35. Phan LH, Mickey MJ, Naizi ZBM, et al. Nitric oxide synthase inhibitor, nitro-iminoethyl-l-ornithine, reduces ischamia-reperfusion injury in rabbit skeletal muscle. Microsurgery 1994;15:703-707
36. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992;262:H611-H615